CORC

浏览/检索结果: 共48条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) 会议论文
作者:  Zhou, J.;  Eng-Wong, J.;  Mao, Y.;  Althaus, B.;  Liao, N.
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/05
A Prediction Model of Acute Esophageal Toxicity in Esophageal Squamous Cell Carcinoma Patients 会议论文
作者:  Jiang, L.;  Lu, S.;  Lu, J.;  Hu, W.;  Wang, J.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
DETECTING HIGH-RISK HUMAN PAPILLOMAVIRUS TYPE DISTRIBUTION AND CLINICOPATHOLOGIC CHARACTERISTICS OF CERVICAL ADENOSQUAMOUS CARCINOMA 会议论文
作者:  Li, J.;  He, T.;  Xiang, L.;  Jiang, W.;  Pei, X.
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y.
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma 会议论文
作者:  Yuan, P.;  Li, Y.;  Jiang, L.;  Liu, Y.;  Liu, W.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer 会议论文
作者:  Jiang, Z.;  Li, W.;  Hu, X.;  Zhang, Q.;  Sun, T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Evaluation of a Novel Beam Angle and Multicriteria Optimization Technique on Liver Cancer 会议论文
作者:  Li, K.;  Jiang, R.;  Wang, J.;  Wang, J.;  Peng, J.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Baseline and early on-treatment HBsAg level to predict HBsAg loss in nucleotide analog suppressed and HBeAg cleared chronic hepatitis B patients by switching to peginterferon alfa-2a: exploratory results of NEW SWITCH study 会议论文
作者:  Hu, P.;  Xie, Q.;  Li, Y.;  Chen, X.;  Dou, X.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Soluble CD163 and their expression on monocytes, constituent potential molecular signature associated with liver inflammation and HBV-specific immune responses 会议论文
作者:  Huang, D.;  Sansass, B.;  Jiang, J.;  Gong, Q.;  Wan, M.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace